Hepatitis C and Alternative Medicine News

Wine and Liver Health (Hepatitis Central)

HCV Cure Associated with Early Drop in Viral Load — Tue, 27 May 2008 19:15:00+0100

Although a study emerging from San Diego claims that a small amount of wine may protect the liver, the researchers admit that this is not true for those already living with liver disease. In fact, there are several more caveats...

What You Must Know About Alcoholic Hepatitis (Hepatitis Central)

Wine and Liver Health — Wed, 14 May 2008 14:25:03+0100

If you think one must be a heavy drinker to suffer from this condition, you ought to read this article. Discover the causes, risk factors and complications of alcoholic hepatitis. Share this information with others. After reading this, anyone with...

Purer, Less Costly Interferon for Hepatitis C and B Treatment (Hepatitis Central)

Good News for Non-Responders to HCV Combination Therapy — Mon, 23 Jun 2008 19:35:22+0100

The Taiwan-based biopharmaceutical company PharmaEssentia Corp. is testing P1101, its third-generation PEG-interferon-alpha drug candidate. Because it is a longer-lasting, purer interferon that is less costly to produce, P1101 could enhance the treatment options for Hepatitis C and B....

Optimism Swells After Liver Conference (Hepatitis Central)

Marijuana Use Sparks Liver Transplant Controversy — Fri, 30 May 2008 19:40:49+0100

Several researchers at the May 2008 Digestive Disease Week in San Diego reported encouraging progress in their mission to extinguish liver disease. One of the advancements announced includes monitoring dendritic cells to determine which Hepatitis C patients will fare well...

New Technology May Help Treat Hepatitis (Hepatitis Central)

Purer, Less Costly Interferon for Hepatitis C and B Treatment — Mon, 23 Jun 2008 19:12:48+0100

While pharmaceutical companies are racing to find safer, more effective treatments for viral Hepatitis C and B, physicists from Arizona have a unique perspective on accomplishing the same goal. Learn how these scientists believe the virus could be rendered harmelss...

New Mexico Offers Free Hepatitis C Hotline (Hepatitis Central)

15 Tips for Managing Interferon-Ribavirin Side Effects — Mon, 12 May 2008 17:52:06+0100

Finally being recognized as the widespread, public health problem that it is, the New Mexico Department of Health has taken a giant step forward to help people with Hepatitis C. By launching a new, toll-free phone number, locals concerned about...

Marijuana Use Sparks Liver Transplant Controversy (Hepatitis Central)

New Breakthrough Could Prevent Hepatitis C Replication — Mon, 02 Jun 2008 16:28:51+0100

Despite its legality in 12 states, learn why medical marijuana use may render a person with Hepatitis C ineligible for a liver transplant....

HCV Viral Load Reduced in Phase I/II Trial (Hepatitis Central)

Fatty Liver Disease is a Major Health Concern — Tue, 10 Jun 2008 19:24:08+0100

Given to those already infected with Hepatitis C, ChronVac-C� is designed to boost the immune response against the virus. Preliminary trial results report a decrease in viral load of over 95 percent in the first patient to complete ChronVac-C� therapy....

HCV Treatment Success: Early Response vs. Genotype (Hepatitis Central)

Alcoholism and Viral Hepatitis — Wed, 11 Jun 2008 17:26:47+0100

As presented at the April 2008 meeting of the European Association for the Study of the Liver, a rapid virological response can help clinicians customize the length of treatment for Hepatitis C ? regardless of genotype....

HCV Cure Associated with Early Drop in Viral Load (Hepatitis Central)

Optimism Swells After Liver Conference — Fri, 30 May 2008 19:37:48+0100

Australian researchers find that the suppression of Hepatitis C viral load within the first month of beginning treatment is a good predictor of defeating the virus - regardless of co-infection with HIV....

Good News for Non-Responders to HCV Combination Therapy (Hepatitis Central)

Hepatitis Central — Fri, 27 Jun 2008 15:35:43+0100

A Phase 3 trial evaluating ZADAXIN� (thymalfasin) as a potential third component for Hepatitis C traditional combination therapy has just been completed. Although the data is currently being analyzed and won't be available until later in the year, the lead...

Fatty Liver Disease is a Major Health Concern (Hepatitis Central)

HCV Treatment Success: Early Response vs. Genotype — Tue, 10 Jun 2008 19:29:54+0100

This liver disorder is incredibly common and its progression to a serious disease is usually preventable....

15 Tips for Managing Interferon-Ribavirin Side Effects (Hepatitis Central)

What You Must Know About Alcoholic Hepatitis — Tue, 13 May 2008 16:12:26+0100

Many people abandon this challenging HCV treatment mid-course. Here are 15 ways to help manage the side effects of Hepatitis C combination therapy, to help patients' likelihood of completing the extremely challenging treatment. Share this article among patients contemplating and/or...

Vancomycin-Resistant Enterococci (VRE) (MedicineNet Infectious Disease General)

Antibiotic Resistance (Drug Resistance, Antimicrobial Resistance) — Thu, 29 May 2008 07:00:00+0100

Title: Vancomycin-Resistant Enterococci (VRE)
Category: Diseases and Conditions
Created: 5/8/2007
Last Editorial Review: 5/29/2008

The case against cure-alls - Sydney Morning Herald (alternative medicine - Google News )

Wed, 18 Jun 2008 14:10:20+0100

The case against cure-alls
Sydney Morning Herald, Australia - Jun 18, 2008
Alternative Medicine On Trial, co-authored with a journalist, Simon Singh. It is a very timely tome, with the Federal Government considering a toughening of ...

Steno 'Superbug' Genome Shows Extreme Drug Resistance (MedicineNet Infectious Disease General)

Silver-Coated Endotracheal Tubes Cut Down on Infections — Mon, 12 May 2008 07:00:00+0100

Title: Steno 'Superbug' Genome Shows Extreme Drug Resistance
Category: Health News
Created: 5/10/2008 2:00:00 AM
Last Editorial Review: 5/12/2008

Silver-Coated Endotracheal Tubes Cut Down on Infections (MedicineNet Infectious Disease General)

Bug Off: Improved Repellents Beat DEET — Tue, 20 May 2008 07:00:00+0100

Title: Silver-Coated Endotracheal Tubes Cut Down on Infections
Category: Health News
Created: 5/20/2008 2:00:00 AM
Last Editorial Review: 5/20/2008

Scientists ID Enzyme That Allows Dysentery Amoeba to Hide (MedicineNet Infectious Disease General)

MRSA Rates Tied to Hospital Understaffing — Fri, 20 Jun 2008 07:00:00+0100

Title: Scientists ID Enzyme That Allows Dysentery Amoeba to Hide
Category: Health News
Created: 6/20/2008 2:00:00 AM
Last Editorial Review: 6/20/2008

Physician and Patient Attitudes towards Complementary and ... ...

Thu, 26 Jun 2008 17:12:01+0100

Physician and Patient Attitudes towards Complementary and ...
7thSpace Interactive (press release), NY - Jun 26, 2008
In the US, complementary and alternative medicine (CAM) use is most prevalent among reproductive age, educated women. We sought to determine general ...

No matter what you call it, integrative medicine growing quickly here - Inside Tucson Business ...

Fri, 27 Jun 2008 23:38:36+0100

No matter what you call it, integrative medicine growing quickly here
Inside Tucson Business, AZ - Jun 27, 2008
Integrative medicine, alternative medicine, holistic medicine, complementary medicine. It goes by many names, but one name that always comes up when Tucson ...

New Breakthrough Could Prevent Hepatitis C Replication (Hepatitis Central)

HCV Viral Load Reduced in Phase I/II Trial — Fri, 06 Jun 2008 22:24:30+0100

Inspired by a pharmaceutical prototype to stop bovine viral diarrhea virus, Immtech reveals that one of their compounds may inhibit Hepatitis C's entry into human cells....

MRSA Rates Tied to Hospital Understaffing (MedicineNet Infectious Disease General)

Abdominal Pain — Wed, 25 Jun 2008 07:00:00+0100

Title: MRSA Rates Tied to Hospital Understaffing
Category: Health News
Created: 6/25/2008 2:00:00 AM
Last Editorial Review: 6/25/2008

MRSA Infections Can Bug Fitness Buffs (MedicineNet Infectious Disease General)

MedicineNet Infectious Disease General — Thu, 03 Jul 2008 07:00:00+0100

Title: MRSA Infections Can Bug Fitness Buffs
Category: Health News
Created: 7/3/2008 2:00:00 AM
Last Editorial Review: 7/3/2008

International Conference in Holgu�n Promotes Natural Alternative ... ...

GP training to include the fringe alternatives - The Age — Thu, 26 Jun 2008 14:50:30+0100

International Conference in Holgu�n Promotes Natural Alternative ...
Radio Nuevitas, Cuba - Jun 26, 2008
Sixty academia studies are to be presented at the conference, which takes place near a flagship alternative medicine hospital in Holgu�n. ...

Germicidal Wipes Can Spread Bacteria (MedicineNet Infectious Disease General)

Bug Bites and Stings — Wed, 04 Jun 2008 07:00:00+0100

Title: Germicidal Wipes Can Spread Bacteria
Category: Health News
Created: 6/4/2008
Last Editorial Review: 6/4/2008

GP training to include the fringe alternatives - The Age (alternative medicine - Google News )

Communication Key to Blending Eastern and Western Medicine - RedOrbit — Fri, 04 Jul 2008 14:07:34+0100

GP training to include the fringe alternatives
The Age, Australia - Jul 4, 2008
But the college says alternative medicine is growing in popularity, and doctors should be able to give reliable advice on these therapies. ...

Doctors in for a dose of alternative medicine - The Age (alternative medicine - Google News )

alternative medicine - Google News — Fri, 04 Jul 2008 14:07:32+0100

Doctors in for a dose of alternative medicine
The Age, Australia - Jul 4, 2008
It gives me a sense that I'm in the right place, somewhere between alternative medicine and Western," he told an interviewer. ...

Complementary medicine: seeking out alternatives - Telegraph.co. ...

Tue, 10 Jun 2008 23:07:11+0100

Telegraph.co.uk
Complementary medicine: seeking out alternatives
Telegraph.co.uk, United Kingdom - Jun 10, 2008
Alternative therapists now outnumber GPs in the UK, universities run courses on alternative medicine and the industry receives �500 million a year from the ...
Alternative therapies put to the test Telegraph.co.uk
all 2 news articles

Communication Key to Blending Eastern and Western Medicine - RedOrbit (alternative medicine - ...

Alternative therapies up close - The Gazette (Montreal) — Mon, 30 Jun 2008 08:32:21+0100

Communication Key to Blending Eastern and Western Medicine
RedOrbit, TX - Jun 30, 2008
Yet alternative medicine is finding its place in health care. "There are some things that Western medicine just can't fix," Evans said. ...

C. diff Epidemic: What You Must Know (MedicineNet Infectious Disease General)

Germicidal Wipes Can Spread Bacteria — Mon, 02 Jun 2008 07:00:00+0100

Title: C. diff Epidemic: What You Must Know
Category: Health News
Created: 6/2/2008
Last Editorial Review: 6/2/2008

Bug Off: Improved Repellents Beat DEET (MedicineNet Infectious Disease General)

Vancomycin-Resistant Enterococci (VRE) — Wed, 28 May 2008 07:00:00+0100

Title: Bug Off: Improved Repellents Beat DEET
Category: Health News
Created: 5/28/2008
Last Editorial Review: 5/28/2008

Bug Bites and Stings (MedicineNet Infectious Disease General)

Scientists ID Enzyme That Allows Dysentery Amoeba to Hide — Thu, 19 Jun 2008 07:00:00+0100

Title: Bug Bites and Stings
Category: Diseases and Conditions
Created: 6/19/2008
Last Editorial Review: 6/19/2008

Antibiotic Resistance (Drug Resistance, Antimicrobial Resistance) (MedicineNet Infectious ...

C. diff Epidemic: What You Must Know — Thu, 29 May 2008 07:00:00+0100

Title: Antibiotic Resistance (Drug Resistance, Antimicrobial Resistance)
Category: Diseases and Conditions
Created: 11/12/2004
Last Editorial Review: 5/29/2008

Alternative therapies up close - The Gazette (Montreal) (alternative medicine - Google News )

Doctors in for a dose of alternative medicine - The Age — Sat, 05 Jul 2008 08:08:26+0100

The Gazette (Montreal)
Alternative therapies up close
The Gazette (Montreal), Canada - 10 hours ago
In Trick or Treatment, British authors Simon Singh and Edzard Ernst expose the false claims and profiteering of alternative medicine while sounding the ...

Alternative Medicine Solutions Markets Naringenin, Grapefruit ... - NewsReleaseWire. ...

Complementary medicine: seeking out alternatives - Telegraph.co.uk — Tue, 24 Jun 2008 22:34:34+0100

NewsReleaseWire.com (press release)
Alternative Medicine Solutions Markets Naringenin, Grapefruit ...
NewsReleaseWire.com (press release) - Jun 24, 2008
Lloyd Wright, CEO of AMS Inc. and author of ?Triumph Over Hepatitis C: An Alternative Medicine Solution,? is currently the only one in the world marketing a ...

Alcoholism and Viral Hepatitis (Hepatitis Central)

New Technology May Help Treat Hepatitis — Mon, 23 Jun 2008 19:04:30+0100

Conquering viral hepatitis is hard enough without the added challenge of alcoholism. The drug gabapentin as a treatment for alcohol dependence is currently being evaluated in human trials....

Abdominal Pain (MedicineNet Infectious Disease General)

MRSA Infections Can Bug Fitness Buffs — Tue, 01 Jul 2008 07:00:00+0100

Title: Abdominal Pain
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 7/1/2008

Expert Recap: Focus on Investigational HCV Agents (Clinical Care Options Hepatitis - HCV )

Clinical Care Options Hepatitis - HCV — Sat, 05 Jul 2008 18:34:15+0100

Ira M. Jacobson, MD, discusses the latest data on novel agents for the treatment of chronic hepatitis C.

Telaprevir Resistance Mutations Emerge Among Hepatitis C Patients Who Relapse Following ...

Multiple Infusions of Bavituximab Safe and Active Against HCV — Sat, 05 Jul 2008 18:34:15+0100

Telaprevir resistance mutations detected following 2 weeks of telaprevir-based therapy and standard peginterferon alfa-2a/ribavirin therapy

Significant Proportion of HCV/HIV-Coinfected Patients Refuse HCV Therapy in Large German ...

Sat, 05 Jul 2008 18:34:15+0100

HCV/HIV-coinfected patients often decline anti-HCV therapy despite tolerability and efficacy of peginterferon alfa-2a plus ribavirin

Short Duration VCH-759 Demonstrates Potent Antiviral Activity in HCV Genotype 1a and 1b ...

Advances in HCV Management Strategies With Approved Agents — Sat, 05 Jul 2008 18:34:15+0100

Novel HCV NS5B polymerase inhibitor, VCH-759, shown to be safe and effective in genotype 1a and 1b patients during short-term study.

Robust Response to Peginterferon alfa-2b Plus Ribavirin Among HCV-Infected IV Drug Users on ...

Sat, 05 Jul 2008 18:34:15+0100

HCV-infected IV drug users undergoing opioid maintenance therapy achieve response rates similar to patients not undergoing opioid therapy when adjusted for age, HCV genotype, and baseline HCV RNA level.

R7128, Promising Therapy for HCV Genotype 1 Nonresponders, Demonstrates Potent Antiviral ...

Sat, 05 Jul 2008 18:34:15+0100

R7128 shown to be well tolerated with significant viral suppression and no viral rebound in HCV genotype 1-infected nonresponders over 14 days.

Peginterferon/Ribavirin/Nitazoxanide Increases Sustained Virologic Response Rate in ...

Sat, 05 Jul 2008 18:34:15+0100

Study suggests potential SVR benefit to interferon-experienced patients with addition of nitazoxanide to standard-of-care peginterferon alfa-2a and ribavirin in genotype 4 HCV patients

PROVE2 Study Shows High SVR Rates With Combination Treatment With Telaprevir, Peginterferon ...

Sat, 05 Jul 2008 18:34:15+0100

Telaprevir in combination with peginterferon alfa-2a plus ribavirin demonstrates strong virologic suppression with minimal adverse events.

PROVE 1 Study: Combination Telaprevir, Peginterferon alfa-2a, and Ribavirin Therapy Has Rapid ...

Sat, 05 Jul 2008 18:34:15+0100

Telaprevir in combination with peginterferon alfa-2a and ribavirin results in high SVR rates treatment-naive HCV genotype 1 patients but is associated with increased incidence of dermatologic and gastrointestinal adverse events.

Multiple Infusions of Bavituximab Safe and Active Against HCV (Clinical Care Options ...

Sat, 05 Jul 2008 18:34:15+0100

Bavituximab administered twice weekly for 2 weeks in HCV patients appears safe and well tolerated at doses up to 6 mg/kg

HCV Polymerase Inhibitor R1626 Has High Genetic Barrier to Resistance With Potent Antiviral ...

Sat, 05 Jul 2008 18:34:15+0100

R1626 with or without peginterferon alfa-2a and ribavirin potently suppresses viral replication in patients chronically infected with HCV genotype 1

HCV Polymerase Inhibitor R1626 Combined With PegIFN/RBV Results in greater than 80% of HCV ...

Sat, 05 Jul 2008 18:34:15+0100

High dosages of R1626 produce robust antiviral effects but are associated with high rates of cytopenias and gastrointestinal adverse events in HCV genotype 1 patients.

HCV FibroSURE and FIBROSpect II Comparable for Fibrosis Staging in Chronic Hepatitis C ...

Sat, 05 Jul 2008 18:34:15+0100

Serodiagnostic marker panel tests FibroSURE and FIBROSpect II have similar positive and negative predictive abilities for staging METAVIR F2-F4 fibrosis.

GI-5005, a Yeast-Based Immunotherapy, Results in Dose-Dependent HCV-Specific Cellular Immune ...

Sat, 05 Jul 2008 18:34:15+0100

Novel immunotherapy, GI-5005, results strong immune response, and some antiviral activity in chronic hepatitis C patients.

Favorable HCV, HBV Outcomes in HCV/HBV-Coinfected Patients Treated With Peginterferon alfa-2a ...

Sat, 05 Jul 2008 18:34:15+0100

Peginterferon alfa-2a plus ribavirin therapy resulted in similar rates of HCV clearance when compared with HCV-monoinfected patients and led to HBsAg clearance in a significant proportion of patients at end-of-treatment follow-up

Expert Analysis: Update on Investigational Agents in HCV: 2007 (Clinical Care Options ...

Expert Recap: Focus on Investigational HCV Agents — Sat, 05 Jul 2008 18:34:15+0100

Nezam H. Afdhal, MD, FRCPI, Ira M. Jacobson, MD, and David R. Nelson, MD review data from the meeting in Boston.

Exper Recap: Update on Investigational Agents in HCV: 2007 (Clinical Care Options Hepatitis - ...

Expert Analysis: Update on Investigational Agents in HCV: 2007 — Sat, 05 Jul 2008 18:34:15+0100

Watch and listen as Ira M. Jacobson, MD, reviews key data on investigational HCV agents presented at the 2007 Boston liver disease meeting.

Development of Model for End-Stage Liver Disease Improved Graft and Overall Survival Rates ...

Exper Recap: Update on Investigational Agents in HCV: 2007 — Sat, 05 Jul 2008 18:34:15+0100

3-year graft and survival rates following liver transplant in HCC patients with and without HCV infection improved after development of MELD

Case: Management of a 38-Year-Old Male on Methadone Maintenance Therapy Who Presents With PCP ...

Sat, 05 Jul 2008 18:34:15+0100

William G. Powderly, MD, discusses selection of initial therapy for a 38-year-old recovering IDU male with HIV/HCV coinfection who presents with PCP.

Biweekly Administration of Controlled-Release Recombinant Interferon alfa-2b Appears to Be ...

Sat, 05 Jul 2008 18:34:15+0100

Phase IIa study of controlled-release recombinant interferon alfa-2b demonstrates potent antiviral activity and is well tolerated among HCV genotype 1-infected, treatment-naive patients

Albinterferon alfa-2b Achieves SVR in Some Hepatitis C Patients Who Failed Previous ...

Sat, 05 Jul 2008 18:34:15+0100

Significant antiviral activity of higher doses of albinterferon alfa-2b in previous interferon/ribavirin HCV nonresponders may not translate into higher SVR rates.

Advances in HCV Management Strategies With Approved Agents (Clinical Care Options Hepatitis - ...

Sat, 05 Jul 2008 18:34:15+0100

Raymond T. Chung, MD, Mitchell L. Shiffman, MD, and Mark S. Sulkowski, MD review new data from the meeting in Boston.

28 Days of Telaprevir, Peginterferon alfa-2a, and Ribavirin Followed by 44 Weeks of ...

Sat, 05 Jul 2008 18:34:15+0100

Telaprevir shown to be safe and effective during combination treatment with peginterferon alfa-2a plus ribavirin among a small cohort of mostly minority patients.